2025 Plenary Keynote Sessions

Tuesday, March 11

8:00 am Chairperson's Remarks
Edward Abrahams, PhD, President, Personalized Medicine Coalition

8:05 am Plenary Keynote Introduction (Sponsorship Available)

8:15 am Plenary Keynote Fireside Chat
Gabriele Allegri, MBA, Vice President, Global Commercial Precision Medicine, Johnson & Johnson Innovative Medicine

Interviewed By:
Edward Abrahams, PhD, President, Personalized Medicine Coalition

8:45 am Panel Discussion: The Pharmaceutical Industry and Precision Medicine
Moderator:

Edward Abrahams, PhD, President, Personalized Medicine Coalition

Panelists:
Steffan Ho, MD, PhD, Vice President, Head of Translational Oncology, Pfizer
Andrea L. Stevens, PhD, Senior Director, Precision Medicine Access, J&J Innovative Medicine
Lourdes Barrera, PhD, Executive Director, Global Medical Affairs Oncology—Precision Medicine, Merck
Omar Perez, PhD, Head of Medical Diagnostics, US Medical Affairs Oncology, AstraZeneca

3:40 pm Chairperson's Remarks
Mara G. Aspinall, Partner, Illumina Ventures; Professor of Practice, Arizona State University; Editor, Sensitive & Specific: The Testing Newsletter

3:45 pm Plenary Keynote Fireside Chat
Peter Foley, Founder & CEO, LetsGetChecked

Interviewed By:
Mara G. Aspinall, Partner, Illumina Ventures; Professor of Practice, Arizona State University; Editor, Sensitive & Specific: The Testing Newsletter

4:15 pm Panel Discussion: Driving Innovation in Precision Medicine: CEO Perspective
Moderator:
Mara G. Aspinall, Partner, Illumina Ventures; Professor of Practice, Arizona State University; Editor, Sensitive & Specific: The Testing Newsletter

Panelists:
Lisa Alderson, CEO, Adela, Inc.
Alex Aravanis, MD, PhD, CEO, Moonwalk Biosciences
Susan Tousi, CEO, DELFI Diagnostics

Wednesday, March 12

8:00 am Chairperson's Remarks
Mara G. Aspinall, Partner, Illumina Ventures; Professor of Practice, Arizona State University; Editor, Sensitive & Specific: The Testing Newsletter

8:05 am Plenary Keynote Introduction (Sponsorship Available)

8:15 am Panel Discussion: Investing in Precision Medicine Innovation: What Defines Success?
Moderator:

Mara G. Aspinall, Partner, Illumina Ventures; Professor of Practice, Arizona State University; Editor, Sensitive & Specific: The Testing Newsletter

Panelists:
Ajit Singh, PhD, Partner, Artiman Ventures
Jenny Rooke, PhD, Managing Director, Genoa Ventures
Michael Hadjisavas, PhD, Executive Advisor, GreyBird Ventures LLC

4:15 pm Panel Discussion: Tech Trends in Precision Medicine
Moderator:
Jonathan D. Grinstein, PhD, North America Editor, Inside Precision Medicine